These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 38075203)

  • 1. Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer.
    Tyagi N; Roy S; Vengadesan K; Gupta D
    Noncoding RNA Res; 2024 Mar; 9(1):66-75. PubMed ID: 38075203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
    Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
    J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancer.
    Zhong W; Wang D; Yao B; Chen X; Wang Z; Qu H; Ma B; Ye L; Qiu J
    J Zhejiang Univ Sci B; 2021 Aug; 22(8):664-681. PubMed ID: 34414701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer.
    Liu T; Liu Y; Su X; Peng L; Chen J; Xing P; Qiao X; Wang Z; Di J; Zhao M; Jiang B; Qu H
    Comput Biol Med; 2023 Feb; 153():106545. PubMed ID: 36646024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
    Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
    Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
    Zhao H; Zhang S; Yin X; Zhang C; Wang L; Liu K; Xu H; Liu W; Bo L; Lin S; Feng K; Lin L; Fei M; Ning S; Wang L
    Front Immunol; 2022; 13():990143. PubMed ID: 36304471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
    Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
    Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of lncRNAs That Influence the Prognosis of Osteosarcoma Based on Copy Number Variation Data.
    Zhang J; Huang C; Zhu G; He G; Xu W; Li J; Wang D; Han K; Shen Z; Liu J
    J Oncol; 2022; 2022():8024979. PubMed ID: 35378771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Three Prognosis-Related Differentially Expressed lncRNAs Driven by Copy Number Variation in Thyroid Cancer.
    Tian J; Luo B
    J Immunol Res; 2022; 2022():9203796. PubMed ID: 35642209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
    Front Oncol; 2023; 13():972558. PubMed ID: 37064115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer.
    Xu Y; Wu T; Li F; Dong Q; Wang J; Shang D; Xu Y; Zhang C; Dou Y; Hu C; Yang H; Zheng X; Zhang Y; Wang L; Li X
    Brief Bioinform; 2020 Dec; 21(6):2153-2166. PubMed ID: 31792500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilizing Liquid-liquid phase separation-related lncRNAs to predict the prognosis and treatment response of PCa.
    Qiu J; Lai C; Yuan Z; Hu J; Wu J; Liu C; Xu K
    Discov Oncol; 2024 Aug; 15(1):352. PubMed ID: 39150479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma.
    Li M; Long S; Hu J; Wang Z; Geng C; Ou S
    Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma.
    Tu G; Peng W; Cai Q; Zhao Z; Peng X; He B; Zhang P; Shi S; Wang X
    Front Genet; 2021; 12():720013. PubMed ID: 34777461
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 19. Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients.
    Qiu Y; Wang HT; Zheng XF; Huang X; Meng JZ; Huang JP; Wen ZP; Yao J
    World J Clin Cases; 2022 Apr; 10(11):3334-3351. PubMed ID: 35611195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in breast cancer: A comprehensive analysis.
    Zhu X; Song J; Wang M; Wang X; Lv L
    J Gene Med; 2023 Mar; 25(3):e3471. PubMed ID: 36525372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.